114 related articles for article (PubMed ID: 38372436)
1. Increased levels of advanced oxidation protein products (AOPPs) were associated with nociceptive behavior and clinical scores in an experimental progressive autoimmune encephalomyelitis model (PMS-EAE).
Rodrigues P; Frare JM; Peres DS; Viero FT; Ruviaro NA; Dos Santos Stein C; da Silva Brum E; Moresco RN; Oliveira SM; Bochi GV; Trevisan G
J Neurochem; 2024 Jun; 168(6):1143-1156. PubMed ID: 38372436
[TBL] [Abstract][Full Text] [Related]
2. Nociception in a Progressive Multiple Sclerosis Model in Mice Is Dependent on Spinal TRPA1 Channel Activation.
Ritter C; Dalenogare DP; de Almeida AS; Pereira VL; Pereira GC; Fialho MFP; Lückemeyer DD; Antoniazzi CT; Kudsi SQ; Ferreira J; Oliveira SM; Trevisan G
Mol Neurobiol; 2020 May; 57(5):2420-2435. PubMed ID: 32095993
[TBL] [Abstract][Full Text] [Related]
3. TRPA1 involvement in depression- and anxiety-like behaviors in a progressive multiple sclerosis model in mice.
Peres DS; Theisen MC; Fialho MFP; Dalenogare DP; Rodrigues P; Kudsi SQ; Bernardes LB; Ruviaro da Silva NA; Lückemeyer DD; Sampaio TB; Pereira GC; Mello FK; Ferreira J; Bochi GV; Oliveira SM; de David Antoniazzi CT; Trevisan G
Brain Res Bull; 2021 Oct; 175():1-15. PubMed ID: 34280479
[TBL] [Abstract][Full Text] [Related]
4. Neuropathic-like Nociception and Spinal Cord Neuroinflammation Are Dependent on the TRPA1 Channel in Multiple Sclerosis Models in Mice.
Dalenogare DP; Souza Monteiro de Araújo D; Landini L; Titiz M; De Siena G; De Logu F; Geppetti P; Nassini R; Trevisan G
Cells; 2023 May; 12(11):. PubMed ID: 37296632
[No Abstract] [Full Text] [Related]
5. TRPA1 activation mediates nociception behaviors in a mouse model of relapsing-remitting experimental autoimmune encephalomyelitis.
Dalenogare DP; Theisen MC; Peres DS; Fialho MFP; Lückemeyer DD; Antoniazzi CTD; Kudsi SQ; Ferreira MA; Ritter CDS; Ferreira J; Oliveira SM; Trevisan G
Exp Neurol; 2020 Jun; 328():113241. PubMed ID: 32045597
[TBL] [Abstract][Full Text] [Related]
6. Antioxidant effect of grape seed extract corrects experimental autoimmune encephalomyelitis behavioral dysfunctions, demyelination, and glial activation.
Mabrouk M; El Ayed M; Démosthènes A; Aissouni Y; Aouani E; Daulhac-Terrail L; Mokni M; Bégou M
Front Immunol; 2022; 13():960355. PubMed ID: 36059517
[TBL] [Abstract][Full Text] [Related]
7. Advanced oxidation protein products sensitized the transient receptor potential vanilloid 1 via NADPH oxidase 1 and 4 to cause mechanical hyperalgesia.
Ding R; Jiang H; Sun B; Wu X; Li W; Zhu S; Liao C; Zhong Z; Chen J
Redox Biol; 2016 Dec; 10():1-11. PubMed ID: 27665186
[TBL] [Abstract][Full Text] [Related]
8. Silencing of the RNA-binding protein HuR attenuates hyperalgesia and motor disability in experimental autoimmune encephalomyelitis.
Sanna MD; Quattrone A; Galeotti N
Neuropharmacology; 2017 Sep; 123():116-125. PubMed ID: 28599923
[TBL] [Abstract][Full Text] [Related]
9. Inosine, an Endogenous Purine Nucleoside, Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis: a Role for A2A Adenosine Receptor.
Junqueira SC; Dos Santos Coelho I; Lieberknecht V; Cunha MP; Calixto JB; Rodrigues ALS; Santos ARS; Dutra RC
Mol Neurobiol; 2017 Jul; 54(5):3271-3285. PubMed ID: 27130268
[TBL] [Abstract][Full Text] [Related]
10. Dopaminergic Receptors as Neuroimmune Mediators in Experimental Autoimmune Encephalomyelitis.
Gonçalves ECD; Lieberknecht V; Horewicz VV; Rabelo BD; Felipetti FA; Rodrigues ALS; Martins DF; Dutra RC
Mol Neurobiol; 2021 Nov; 58(11):5971-5985. PubMed ID: 34432265
[TBL] [Abstract][Full Text] [Related]
11. The role of kinin B1 and B2 receptors in the persistent pain induced by experimental autoimmune encephalomyelitis (EAE) in mice: evidence for the involvement of astrocytes.
Dutra RC; Bento AF; Leite DF; Manjavachi MN; Marcon R; Bicca MA; Pesquero JB; Calixto JB
Neurobiol Dis; 2013 Jun; 54():82-93. PubMed ID: 23454198
[TBL] [Abstract][Full Text] [Related]
12. Changes in nociceptive sensitivity and object recognition in experimental autoimmune encephalomyelitis (EAE).
Olechowski CJ; Tenorio G; Sauve Y; Kerr BJ
Exp Neurol; 2013 Mar; 241():113-21. PubMed ID: 23291347
[TBL] [Abstract][Full Text] [Related]
13. Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE).
Olechowski CJ; Truong JJ; Kerr BJ
Pain; 2009 Jan; 141(1-2):156-64. PubMed ID: 19084337
[TBL] [Abstract][Full Text] [Related]
14. Establishment and characterization of an optimized mouse model of multiple sclerosis-induced neuropathic pain using behavioral, pharmacologic, histologic and immunohistochemical methods.
Khan N; Woodruff TM; Smith MT
Pharmacol Biochem Behav; 2014 Nov; 126():13-27. PubMed ID: 25223977
[TBL] [Abstract][Full Text] [Related]
15. Anti-IL-6 receptor antibody improves pain symptoms in mice with experimental autoimmune encephalomyelitis.
Serizawa K; Tomizawa-Shinohara H; Magi M; Yogo K; Matsumoto Y
J Neuroimmunol; 2018 Jun; 319():71-79. PubMed ID: 29685293
[TBL] [Abstract][Full Text] [Related]
16. Advanced oxidation protein products induce microglia-mediated neuroinflammation via MAPKs-NF-κB signaling pathway and pyroptosis after secondary spinal cord injury.
Liu Z; Yao X; Jiang W; Li W; Zhu S; Liao C; Zou L; Ding R; Chen J
J Neuroinflammation; 2020 Mar; 17(1):90. PubMed ID: 32192500
[TBL] [Abstract][Full Text] [Related]
17. Alpha-lipoic acid reduces nociception by reducing oxidative stress and neuroinflammation in a model of complex regional pain syndrome type I in mice.
Rodrigues P; Cassanego GB; Peres DS; Viero FT; Kudsi SQ; Ruviaro NA; Aires KV; Portela VM; Bauermann LF; Trevisan G
Behav Brain Res; 2024 Feb; 459():114790. PubMed ID: 38040057
[TBL] [Abstract][Full Text] [Related]
18. Elevated serum [Met
Ludwig MD; Zagon IS; McLaughlin PJ
Brain Res Bull; 2017 Sep; 134():1-9. PubMed ID: 28647454
[TBL] [Abstract][Full Text] [Related]
19. The chloride co-transporters, NKCC1 and KCC2, in experimental autoimmune encephalomyelitis (EAE).
Yousuf MS; Zubkow K; Tenorio G; Kerr B
Neuroscience; 2017 Mar; 344():178-186. PubMed ID: 28057537
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological inhibition of the NLRP3 inflammasome as a potential target for multiple sclerosis induced central neuropathic pain.
Khan N; Kuo A; Brockman DA; Cooper MA; Smith MT
Inflammopharmacology; 2018 Feb; 26(1):77-86. PubMed ID: 28965161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
